跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,357 条关于
“VXV-01”
全部
3,357
临床试验
1,208
药物
1,452
机构
113
资讯
584
11个月前
Appili Therapeutics Secures $40 Million NIAID Contract to Develop First-in-Class Fungal Vaccine VXV-01
10个月前
Appili Therapeutics Secures $40 Million NIAID Contract for Antifungal Vaccine Development
2个月前
Appili Therapeutics Reports FY2026 Results, Highlights US$40M NIAID Award for Antifungal Vaccine and LIKMEZ Commercial Momentum
去年
Breakthrough Humanized Antibody VX-01 Shows Promise Against Deadly Mucormycosis
去年
Kiromic BioPharma's Deltacel Shows Promise in NSCLC Trial, Moves to Dose Expansion
去年
Relmada Therapeutics Secures Licensing for Novel Bladder Cancer Treatment NDV-01
前天
Avacta Reports Clinical Proof of Mechanism for FAP-Activated Exatecan PDC AVA6103 in Phase 1 FOCUS-01
去年
SKYSCRAPER-01: Tiragolumab Plus Atezolizumab Fails to Improve Overall Survival in PD-L1-High NSCLC
2年前
Greenwich LifeSciences' Flamingo-01 Trial Expands into Europe and Broadens Patient Enrollment
去年
FDA Fast-Tracks Novel Drug PP-01 for Cannabis Withdrawal Syndrome Treatment
第 1 页,共 59 页
上一页
下一页